AU4077193A - Alpha-aminoboronic acid peptides and their use as elastase inhibitors - Google Patents

Alpha-aminoboronic acid peptides and their use as elastase inhibitors

Info

Publication number
AU4077193A
AU4077193A AU40771/93A AU4077193A AU4077193A AU 4077193 A AU4077193 A AU 4077193A AU 40771/93 A AU40771/93 A AU 40771/93A AU 4077193 A AU4077193 A AU 4077193A AU 4077193 A AU4077193 A AU 4077193A
Authority
AU
Australia
Prior art keywords
alpha
acid peptides
elastase inhibitors
aminoboronic acid
aminoboronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40771/93A
Inventor
Peter Robert Bernstein
Andrew Shaw
Ashokkumar Bhikkappa Shenvi
Royston Martin Thomas
Peter Warner
Donald John Wolanin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929208387A external-priority patent/GB9208387D0/en
Priority claimed from GB929217366A external-priority patent/GB9217366D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of AU4077193A publication Critical patent/AU4077193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40771/93A 1992-04-16 1993-04-15 Alpha-aminoboronic acid peptides and their use as elastase inhibitors Abandoned AU4077193A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9208387 1992-04-16
GB929208387A GB9208387D0 (en) 1992-04-16 1992-04-16 Heterocyclic derivatives
GB9217366 1992-08-14
GB929217366A GB9217366D0 (en) 1992-08-14 1992-08-14 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
AU4077193A true AU4077193A (en) 1993-11-18

Family

ID=26300738

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40771/93A Abandoned AU4077193A (en) 1992-04-16 1993-04-15 Alpha-aminoboronic acid peptides and their use as elastase inhibitors

Country Status (5)

Country Link
EP (1) EP0636144A1 (en)
JP (1) JPH07505875A (en)
AU (1) AU4077193A (en)
CA (1) CA2133658A1 (en)
WO (1) WO1993021213A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693617A (en) * 1994-03-15 1997-12-02 Proscript, Inc. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US5756466A (en) 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) * 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
EP0977772A1 (en) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6211183B1 (en) 1997-04-14 2001-04-03 Cor Therapeutics, Inc. Selective factor Xa inhibitors
AU6896398A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US7122627B2 (en) 1999-07-26 2006-10-17 Bristol-Myers Squibb Company Lactam inhibitors of Hepatitis C virus NS3 protease
CA2376961A1 (en) * 1999-07-26 2001-02-01 Bristol-Myers Squibb Pharma Company Lactam inhibitors of hepatitis c virus ns3 protease
WO2013084199A1 (en) * 2011-12-07 2013-06-13 Universidade De Lisboa Boron heterocycles as new inhibitors of human neutrophil elastase
JP6268014B2 (en) * 2014-03-20 2018-01-24 富士フイルム株式会社 Compounds useful for the production of salacinol and methods for producing them, methods for producing salacinol, methods for protecting and deprotecting diol groups, and protecting agents for diol groups
BR112022004861A2 (en) 2019-09-17 2022-06-07 Univ Duke Alvestat for use in the treatment of transplant rejection, bronchiolitis obliterans syndrome and transplant versus host disease
EP4106757B1 (en) 2020-04-16 2023-08-23 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
CN118265527A (en) 2021-10-20 2024-06-28 美莱奥生物制药第四有限公司 Neutrophil elastase inhibitors for the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315574A3 (en) * 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin inhibitors
US4963655A (en) * 1988-05-27 1990-10-16 Mayo Foundation For Medical Education And Research Boron analogs of amino acid/peptide protease inhibitors
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides

Also Published As

Publication number Publication date
WO1993021213A1 (en) 1993-10-28
JPH07505875A (en) 1995-06-29
EP0636144A1 (en) 1995-02-01
CA2133658A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
AU4077193A (en) Alpha-aminoboronic acid peptides and their use as elastase inhibitors
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU4543193A (en) Scar inhibitory factor and use thereof
AU3105493A (en) Quinolone- and naphthyridone-carboxylic acid derivatives
AU1081292A (en) New beta-amino- alpha-hydroxycarboxylic acids and their use
AU6955394A (en) Vascularization inhibitor and novel compound
AU667757B2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives
AU3731293A (en) Protein kinase c inhibitor
AU7930394A (en) Pyrimidinyl-glutamic acid derivatives
AU5067193A (en) Pyranoquinolines and their use as pharmaceuticals
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU5825194A (en) Novel amino acid derivatives
AU3160893A (en) Novel bisphosphonic acid derivatives and their use
AU4848193A (en) Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents
AU1064895A (en) 3-methoxy-phenyl-acrylic acid methyl esters
AU6723294A (en) Use of simmondsine
AU5773794A (en) 4-amino-3-hydroxycarboxylic acid and their use as anitvirals
AU7001796A (en) Benzoic acid compounds and medicinal use thereof
AU4849593A (en) Myocyte-specific transcription enhancing factor 2
AU5418794A (en) Propenoic ester derivatives having pyrazole group and the use
AU5758894A (en) Acyloxyhexanoic acid derivatives
AU6944696A (en) Novel phenylacetic acid derivatives and medicinal composition containing the same
AU3494293A (en) Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
AU2792695A (en) Amino acid derivatives and their use as pesticides
AU7534894A (en) 3-methoxy-2-phenylacrylic acid methyl esters